Before nonsteroidal anti-inflammatory drugs NSAIDs are indicated, risk factors such as age, the use of other drugs potentially harmful to the gastrointestinal tract, smoking, and concomitant use of aspirin should be evaluated, to select the most appropriate option for each patient and determine the need for gastroprotective therapy.
Because of the possibility of cardiovascular risk posed by COX-2 selective NSAIDs, cardiovascular risk factors should also be analyzed in each patient before starting treatment of this type, mainly bearing in mind that the protective effect of COX-2 selective NSAIDs is substantially reduced in patients taking aspirin.. Efectos gastrointestinales graves por antiinflamatorios no esteroideos. Un problema no resuelto.
Upper gastrointestinal events associated with nonsteroidal anti-inflammatory drugs usage. Recibido 15 septiembre , Aceptado 29 septiembre Resumen. Because of the possibility of cardiovascular risk posed by COX-2 selective NSAIDs, cardiovascular risk factors should also be analyzed in each patient before starting treatment of this type, mainly bearing in mind that the protective effect of COX-2 selective NSAIDs is substantially reduced in patients taking aspirin.
Epidemiology of nonsteroidal-antiinflammmatory drug-associated gastrointestinal injury. Am J Med, , pp. N Engl J Med, , pp. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: Arch Intern Med, , pp. Gut, 26 , pp.
Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut, 28 , pp. Arthritis Rheum, 40 , pp. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Pharm Ther J, 27 , pp. J Rheumatol, 24 , pp. Specific inhibition of cyclooxygenase-2 with MK is associated with less gastsroduodenal damage than aspirin or ibuprofen. Aliment Pharmacol Ther, 13 , pp. Outcomes studies of the gastrointestinal safety of cyclo-oxygenase-2 inhibitors.
Cleve Clin J Med, 69 , pp. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: BMJ, , pp. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
JAMA, , pp. J Clin Epidemiol, 55 , pp. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori and smoking. J Clin Gastroenterol, 24 , pp. Association between aspirin and upper gastrointestinal complications: Br J Clin Pharmacol, 52 , pp. Risk of uncomplicaated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol, , pp. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events.
Risk of gastrointestinal hemorrhage with long term use of aspirin: Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. J Clin Gastroenterol, 21 , pp. Prophylactic aspirin and risk of peptic ulcer bleeding.
Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol, 95 , pp. A look at the safety profile of over-the- counter naproxen sodium: J Clin Pharmacol, 41 , pp. Risk for serous gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med, , pp. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol, 29 , pp. Approaches to nonsteroidal anti-inflammatory drug use in the high risk patients.
Gastroenterology, , pp. J Clin Rheumatol, 10 , pp. J Biol Chem, , pp. Prostaglandin H synthase isoenzyme activity: Am J Med, 95 , pp. Non-steroidal anti-inflammatory drugs and gastrointewstinal damage-problems and solutions. Postgrad Med J, 77 , pp.
Reduced risk of upper gastrointestinal ulcer complications with celecoxib a novel COX-2 inhibitor. A lower incidence of upper-GI perforations, ulcers and bleeds PUBs in patients treated with etoricoxib vs. Arthritis Rheum, Suppl 44 , pp.
Gastrointestinal toxicity with celecoxib vs. Celecoxib Long-term Arthritis Safety Study. European League Against Rheumatism, Lancet, , pp. Observational study of upper gastrointestinal hemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.
Nonsteroidal anti-inflammatory drug toxicity: Scand J Rheumatol Suppl, 91 , pp. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Risk stratification of upper gastrointestinal bleeding in cardiovascular patients on low-dose aspirin. A cohort study [abstract]. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents.
Arthritis Res, 3 , pp. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Br J Clin Pharmacol, 53 , pp. Gastrointestinal safety of coxibs and outcomes studies what's the verdict?. J Pain Symptom Manage, 23 , pp. Gastrointestinal safety of COX-2 specific inhibition. Gastroenterol Clin North Am, 30 , pp. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis.
Rheumatology Oxford , 43 , pp. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nosteroidal anti-inflammatory dugs. Cochrane Database Syst Rev, ,. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Primary gastroduodenal prophylaxis with omeprazole for nonsteroidal anti-inflammatory drug users.
Aliment Pharmacol Ther, 12 , pp. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-sterol anti-inflammatory drug therapy. A Nordic multicentre study.
Sand J Gastroenterol, 31 , pp. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent uler bleeding in patients with arthritis. Pharmacol Ther, 27 , pp.
Colonia Chapalita Campo de Polo.